E1	Age:T1 Eq-Comparison:E2
E2	Eq-Comparison:T2 Operator:T104 Value:T105 Temporal-Unit:T106
E3	Modifier:T3 Modifies:T108
E4	Or:T4 Arg:E3 Arg2:E5
E5	Procedure:T5 Name:T107
E6	Condition:T6 Name:T108
E7	Modifier:T7 Modifies:T108
E8	Or:T8 Arg:E7 Arg2:E9
E9	Modifier:T9 Modifies:T108
E10	Procedure:T10 Name:T109
E11	Condition:T11 Name:T110
E12	Temporal-Connection:T12 Arg:E11 Arg2:E13
E13	Eq-Comparison:T13 Temporal-Period:T111
E14	Procedure:T14 Temporality:E13
E15	Modifier:T15 Modifies:T113
E16	Or:T16 Arg:E15 Arg2:E17
E17	Modifier:T17 Modifies:T113
E18	Drug:T18 Name:T113
E19	Drug:T19 Name:T114
E20	Or:T20 Arg:E19 Arg2:E21
E21	Drug:T21 Name:T115
E22	Condition:T22 Name:T116 Polarity:T117
E23	Temporal-Connection:T23 Arg:E22 Arg2:E24
E24	Condition:T24 Name:T118
E25	Eq-Comparison:T25 Temporal-Period:T119
E26	Drug:T26 Temporality:E25 Name:T172
E27	Observation:T27 Name:T120
E28	Observation:T28 Name:T121 Eq-Comparison:E29
E29	Eq-Comparison:T29 Value:T122 Operator:T123
E30	Observation:T30 Name:T126 Eq-Comparison:E31
E31	Eq-Comparison:T31 Value:T127 Temporal-Unit:T128 Operator:T125
E32	Eq-Comparison:T32 Operator:T129 Value:T130
E33	Condition:T33 Name:T131 Minimum-Count:E32
E34	Negation:T34 Negates:E36
E35	Eq-Comparison:T35 Temporal-Period:T132
E36	Procedure:T36 Name:T173 Temporality:E35
E37	Temporal-Connection:T37 Arg:E36 Arg2:E38
E38	Study:T38
E40	Assertion:T40 Asserted:E39
E41	Temporal-Connection:T41 Arg:E39 Arg2:E42
E42	Study:T42
E43	Assertion:T43 Asserted:E44
E44	Procedure:T44 Name:T176
E45	Temporal-Connection:T45 Arg:E44 Arg2:E46
E46	Study:T46
E47	And:T47 Arg:E46 Arg2:E48
E48	Eq-Comparison:T48 Operator:T133 Value:T134 Temporal-Unit:T135
E49	Temporal-Connection:T49 Arg:E48 Arg2:E50
E50	Eq-Comparison:T50 Temporal-Recency:T136
E52	Condition:T52 Name:T137 Temporality:E50
E53	Assertion:T53 Asserted:E51
E54	Condition:T54 Name:T139
E55	Observation:T55 Name:T141 Polarity:T140
E56	Or:T56 Arg:E51 Arg2:E57
E57	Negation:T57 Negates:E58
E58	Condition:T58 Name:T142
E59	Procedure:T59
E60	Modifier:T60 Modifies:T143
E61	Or:T61 Arg:E60 Arg2:E62
E62	Modifier:T62 Modifies:T143
E63	Drug:T63 Name:T143 Temporality:E64
E64	Eq-Comparison:T64 Operator:T144 Value:T145 Temporal-Unit:T146
E65	Temporal-Connection:T65 Arg:E64 Arg2:E66
E66	Study:T66
E68	Eq-Comparison:T68 Temporal-Period:T147
E69	Procedure:T69 Temporality:E68
E71	Drug:T71 Name:T148
E72	Eq-Comparison:T72 Temporal-Period:T70
E73	Condition:T73 Name:T149 Temporality:E72
E74	Eq-Comparison:T74 Temporal-Period:T150
E75	Procedure:T75 Name:T151 Temporality:E74
E77	Condition:T77 Name:T152 Stability:T76
E78	Or:T78 Arg:E77 Arg2:E80
E79	Modifier:T79 Modifies:T153
E80	Condition:T80 Name:T153
E81	Or:T81 Arg:T154 Arg2:E82
E82	Modifier:T82 Modifies:T155
E84	Condition:T84 Name:T155 Severity:T154
E85	Modifier:T85 Modifies:T156
E86	Condition:T86 Name:T156
E87	Condition:T87 Name:T157
E89	Or:T89 Arg:E87 Arg2:E90
E90	Condition:T90 Name:T158
E91	Eq-Comparison:T91 Unit:T178 Operator:T159 Value:T177
E92	Temporal-Connection:T92 Arg:E70 Arg2:E93
E93	Study:T93
E94	Condition:T94 Name:T161 Severity:T160
E95	Condition:T95 Name:T162
E96	Condition:T96 Name:T164 Severity:T163
E97	Condition:T97 Name:T165
E98	Eq-Comparison:T98 Temporal-Period:T166
E99	Procedure:T99 Minimum-Count:E100
E100	Eq-Comparison:T100 Value:T167 Operator:T168
E101	Procedure:T101 Name:T169
E102	Or:T102 Arg:E101 Arg2:E103
E103	Procedure:T103 Name:T170
E104	Modifier:T112 Modifies:E14
E105	Temporal-Connection:T171 Arg:E24 Arg2:E25
E39	Observation:T39 Name:T174
E106	And:T175 Arg:E38 Arg2:E40
E51	Negation:T51 Negates:E54
E67	Modifier:T67 Modifies:T148
E70	Observation:T83 Name:T88 Eq-Comparison:E91
T1	Age 31 29	Aged
T2	Eq-Comparison 50 47	at least 18 years
T3	Modifier 73 68	Histologically
T4	Or 76 71	or
T5	Procedure 90 85	cytologically
T6	Condition 116 111	NSCLC
T7	Modifier 141 136	locally advanced
T8	Or 144 139	or
T9	Modifier 155 150	metastatic
T10	Procedure 176 169	Radiological
T11	Condition 213 206	disease progression
T12	Temporal-Connection 219 212	while
T13	Eq-Comparison 233 226	previous
T14	Procedure 254 247	treatment
T15	Modifier 268 261	first
T16	Or 271 264	or
T17	Modifier 289 282	second generation
T18	Drug 301 294	EGFR TKI
T19	Drug 320 309	gefitinib
T20	Or 323 312	or
T21	Drug 333 322	erlotinib
T22	Condition 405 390	tumour T790M mutation
T23	Temporal-Connection 441 424	after
T24	Condition 461 444	disease progression
T25	Eq-Comparison 474 457	prior
T26	Drug 483 466	EGFR TKI
T27	Observation 545 526	Eastern cooperative oncology group performance status
T28	Observation 552 532	ECOG
T29	Eq-Comparison 565 542	0-
T30	Observation 601 575	life expectancy
T31	Eq-Comparison 614 587	12 weeks
T32	Eq-Comparison 635 606	At least one
T33	Condition 642 613	lesion
T34	Negation 648 618	not
T35	Eq-Comparison 659 629	previously
T36	Procedure 670 640	irradiated
T37	Temporal-Connection 677 647	during
T38	Study 687 657	study
T40	Assertion 718 687	can be
T41	Temporal-Connection 741 710	at
T42	Study 750 719	baseline
T43	Assertion 791 758	Agree to
T44	Procedure 840 807	contraceptive
T45	Temporal-Connection 856 823	during
T46	Study 873 840	study
T47	And 884 851	and
T48	Eq-Comparison 900 866	within 6 weeks
T49	Temporal-Connection 906 872	after
T50	Eq-Comparison 915 881	last
T52	Condition 947 911	pre-menopausal fertility
T53	Assertion 981 945	need to
T54	Condition 999 963	pregnancy
T55	Observation 1028 991	pregnancy test
T56	Or 1034 996	and
T57	Negation 1041 1003	non
T58	Condition 1053 1013	lactation
T59	Procedure 1100 1056	Treatment
T60	Modifier 1113 1069	first
T61	Or 1116 1072	or
T62	Modifier 1134 1090	second generation
T63	Drug 1148 1102	EGFR-TKI
T64	Eq-Comparison 1163 1116	within 7 days
T65	Temporal-Connection 1166 1119	of
T66	Study 1172 1125	study
T68	Eq-Comparison 1188 1141	previous
T69	Procedure 1198 1151	treatment
T71	Drug 1236 1187	EGFR-TKI
T72	Eq-Comparison 1255 1204	Unresolved
T73	Condition 1266 1215	toxicities
T74	Eq-Comparison 1277 1226	prior
T75	Procedure 1285 1234	therapy
T77	Condition 1326 1273	spinal cord compression
T78	Or 1328 1274	/
T79	Modifier 1334 1279	brain
T80	Condition 1345 1290	metastases
T81	Or 1362 1304	/
T82	Modifier 1384 1325	uncontrolled systemic
T84	Condition 1393 1334	diseases
T85	Modifier 1418 1358	uncontrolled
T86	Condition 1431 1371	hypertension
T87	Condition 1452 1391	bleeding diatheses
T89	Or 1455 1394	or
T90	Condition 1465 1404	infection
T91	Eq-Comparison 1490 1424	>470 msec
T92	Temporal-Connection 1497 1431	during
T93	Study 1511 1445	screening
T94	Condition 1554 1486	respiratory diseases
T95	Condition 1588 1520	interstitial lung disease
T96	Condition 1604 1535	asthma
T97	Condition 1625 1555	pulmonary embolism
T98	Eq-Comparison 1648 1575	previous
T99	Procedure 1658 1585	treatment
T100	Eq-Comparison 1674 1600	2 or more
T101	Procedure 1696 1622	Chemotherapy
T102	Or 1699 1625	or
T103	Procedure 1713 1639	immunotherapy
T104	Eq-Operator 40 38	at least
T105	Eq-Value 44 41	18
T106	Eq-Temporal-Unit 50 47	years
T107	Procedure-Name 90 85	cytologically
T108	Condition-Name 116 111	NSCLC
T110	Condition-Name 213 206	disease progression
T111	Eq-Temporal-Period 233 226	previous
T113	Drug-Name 301 294	EGFR TKI
T114	Drug-Name 320 309	gefitinib
T115	Drug-Name 333 322	erlotinib
T116	Condition-Name 405 390	tumour T790M mutation
T117	Polarity 433 417	positive
T118	Condition-Name 461 444	disease progression
T119	Eq-Temporal-Period 474 457	prior
T120	Observation-Name 545 526	Eastern cooperative oncology group performance status
T121	Observation-Name 552 532	ECOG
T122	Eq-Value 563 541	0
T123	Eq-Operator 565 542	-
T124	Eq-Value 568 543	1
T125	Eq-Operator 585 559	minimum
T126	Observation-Name 601 575	life expectancy
T127	Eq-Value 608 581	12
T128	Eq-Temporal-Unit 614 587	weeks
T129	Eq-Operator 631 602	At least
T130	Eq-Value 635 606	one
T131	Condition-Name 642 613	lesion
T132	Eq-Temporal-Period 659 629	previously
T133	Eq-Operator 891 858	within
T134	Eq-Value 894 860	6
T135	Eq-Temporal-Unit 900 866	weeks
T136	Eq-Temporal-Recency 915 881	last
T137	Condition-Name 947 911	pre-menopausal fertility
T138	Life-Stage-And-Gender 964 928	Female
T139	Condition-Name 999 963	pregnancy
T140	Polarity 1013 976	negative
T141	Observation-Name 1028 991	pregnancy test
T142	Condition-Name 1053 1013	lactation
T143	Drug-Name 1148 1102	EGFR-TKI
T144	Eq-Operator 1155 1109	within
T145	Eq-Value 1158 1111	7
T146	Eq-Temporal-Unit 1163 1116	days
T147	Eq-Temporal-Period 1188 1141	previous
T148	Drug-Name 1236 1187	EGFR-TKI
T149	Condition-Name 1266 1215	toxicities
T150	Eq-Temporal-Period 1277 1226	prior
T151	Procedure-Name 1285 1234	therapy
T152	Condition-Name 1326 1273	spinal cord compression
T153	Condition-Name 1345 1290	metastases
T154	Severity 1360 1303	Severe
T155	Condition-Name 1393 1334	diseases
T156	Condition-Name 1431 1371	hypertension
T157	Condition-Name 1452 1391	bleeding diatheses
T158	Condition-Name 1465 1404	infection
T160	Severity 1533 1465	Severe
T161	Condition-Name 1554 1486	respiratory diseases
T162	Condition-Name 1588 1520	interstitial lung disease
T163	Severity 1597 1528	severe
T164	Condition-Name 1604 1535	asthma
T165	Condition-Name 1625 1555	pulmonary embolism
T166	Eq-Temporal-Period 1648 1575	previous
T167	Eq-Value 1666 1592	2
T168	Eq-Operator 1674 1600	or more
T169	Procedure-Name 1696 1622	Chemotherapy
T170	Procedure-Name 1713 1639	immunotherapy
T109	Procedure-Name 176 169	Radiological
T112	Modifier 244 237	continuous
T171	Temporal-Connection 464 447	on
T172	Drug-Name 483 466	EGFR TKI
T173	Procedure-Name 670 640	irradiated
T39	Observation 738 707	measured
T174	Observation-Name 738 707	measured
T175	And 711 680	that
T176	Procedure-Name 840 807	contraceptive
T51	Negation 989 953	exclude
T67	Modifier 1222 1175	third generation
T70	Eq-Temporal-Period 1255 1204	Unresolved
T76	Stability 1302 1249	Unstable
T83	Observation 1478 1415	QTcF
T88	Observation-Name 1478 1415	QTcF
T159	Eq-Operator 1480 1416	>
T177	Eq-Value 1485 1419	470
T178	Eq-Unit 1490 1424	msec
A1	Temporal-Connection-Type-Value E12 during
A2	Temporal-Connection-Type-Value E23 after
A3	Temporal-Connection-Type-Value E37 during
A4	Assertion-Type-Value E40 hypothetical
A5	Temporal-Connection-Type-Value E41 during
A6	Assertion-Type-Value E43 hypothetical
A7	Temporal-Connection-Type-Value E45 during
A8	Temporal-Connection-Type-Value E49 after
A10	Assertion-Type-Value E53 hypothetical
A11	Temporal-Connection-Type-Value E65 before
A12	Temporal-Connection-Type-Value E92 during
A13	Eq-Operator-Value T104 GTEQ
A14	Eq-Temporal-Unit-Value T106 year
A15	Eq-Temporal-Period-Value T111 past
A17	Polarity-Value T117 positive
A18	Eq-Temporal-Period-Value T119 past
A19	Observation-Type-Value T120 clinical-score
A20	Eq-Operator-Value T123 BETWEEN
A21	Eq-Operator-Value T125 GTEQ
A22	Eq-Temporal-Unit-Value T128 week
A23	Eq-Operator-Value T129 GTEQ
A24	Eq-Temporal-Period-Value T132 past
A25	Eq-Operator-Value T133 LTEQ
A26	Eq-Temporal-Unit-Value T135 week
A28	Life-Stage-And-Gender-Type T138 female
A29	Polarity-Value T140 negative
A30	Observation-Type-Value T141 lab
A31	Eq-Operator-Value T144 LTEQ
A32	Eq-Temporal-Unit-Value T146 day
A33	Eq-Temporal-Period-Value T147 past
A34	Eq-Temporal-Period-Value T150 past
A35	Severity-Value T154 severe
A36	Severity-Value T160 severe
A37	Severity-Value T163 severe
A38	Eq-Temporal-Period-Value T166 past
A39	Eq-Operator-Value T168 GTEQ
A16	Temporal-Connection-Type-Value E105 during
A40	Observation-Type-Value T174 measurement
A27	Eq-Temporal-Recency-Value T136 most-recent-time
A9	Eq-Temporal-Period-Value T70 present
A41	Stability-Value T76 change
A42	Observation-Type-Value T88 measurement
A43	Eq-Operator-Value T159 GT
R1	Found-By Arg1:E6 Arg2:E5
R2	Found-By Arg1:E11 Arg2:E10
R3	Example-Of Arg1:E19 Arg2:E18
R4	Example-Of Arg1:E21 Arg2:E19
R5	Using Arg1:E14 Arg2:E18
R6	Abbrev-Of Arg1:E28 Arg2:E27
R7	If-Then Arg1:T138 Arg2:E53
R8	Equivalent-To Arg1:E55 Arg2:E51
R9	Using Arg1:E59 Arg2:E63
R10	Using Arg1:E69 Arg2:E71
R11	Caused-By Arg1:E73 Arg2:E75
R12	Example-Of Arg1:E86 Arg2:E84
R13	Example-Of Arg1:E87 Arg2:E84
R14	Example-Of Arg1:E90 Arg2:E84
R15	Example-Of Arg1:E95 Arg2:E94
R16	Example-Of Arg1:E96 Arg2:E94
R17	Example-Of Arg1:E97 Arg2:E94
R18	Equivalent-To Arg1:E99 Arg2:E98
R19	Using Arg1:E99 Arg2:E101
R20	Using Arg1:E99 Arg2:E103